Next-generation multifunctional precision immunotherapies
Bright Peak Therapeutics is a biotechnology company advancing next-generation multifunctional precision immunotherapies. The company uses world-class protein engineering capabilities to create multi-functional PD-1 inhibitors, integrating both novel and validated mechanisms. Co-founded in 2017 by Vijaya Pattabiraman and Jeffrey Bode, Bright Peak is backed by leading healthcare investors including Versant Ventures, Fidelity Management & Research Company, RA Capital Management, Qatar Investment Authority, Invus, Alexandria Venture Investments, Venrock, and KB Investment. The company is co-located in Basel, Switzerland and San Diego (Del Mar), California, with a dual focus on cancer and autoimmune diseases.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2024
Jun 2021
Jul 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
